Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Эндокринологические аспекты бариатрической хирургии
________________________________________________
Troshina E.A., Ershova E.V., Mazurina N.V. Endocrinological aspects of bariatric surgery. Consilium Medicum. 2019; 21 (4): 50–55. DOI: 10.26442/20751753.2019.4.190336
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Ключевые слова: ожирение, сахарный диабет 2-го типа, бариатрические операции, метаболический контроль.
________________________________________________
Key words: obesity, diabetes mellitus type 2, bariatric surgery, metabolic control.
[Bondarenko I.Z., Butrova S.A., Goncharov N.P. et al. Lechenie morbidnogo ozhireniia. Natsional'nye klinicheskie rekomendatsii. Ozhirenie i metabolizm. 2018; 1: 53–70
(in Russian).]
2. Fried M, Yumuk V, Oppert J et al. Interdisciplinary European guidelines on metabolic and bariatric surgery. International Federation for the Surgery of Obesity and Metabolic Disorders – European Chapter (IFSO – EC) and European Association for the Study of Obesity (EASO). Obes Surg 2014; 24 (1): 42–55.
3. The Diabetes Surgery Summit Consensus Conference: Recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes. Ann Surg. 2010; 251 (3): 399–405.
4. Яшков Ю.И., Ершова Е.В. «Метаболическая» хирургия. Ожирение и метаболизм. 2011; 3: 65–8.
[Iashkov Iu.I., Ershova E.V. "Metabolicheskaia' khirurgiia. Ozhirenie i metabolizm. 2011; 3: 65–8 (in Russian).]
5. Flancbaum L. Mechanisms of weight loss after surgery for clinically severe obesity. Obes Surg 1999; 9 (6): 516–23.
6. Buchwald H, Varco R. Metabolic Surgery. New York: Grune & Stratton, 1978.
7. Дедов И.И., Яшков Ю.И., Ершова Е.В. Инкретины и их влияние на течение сахарного диабета 2 типа у пациентов с морбидным ожирением после бариатрических операций. Ожирение и метаболизм. 2012; 2: 3–10.
[Dedov I.I., Iashkov Iu.I., Ershova E.V. Inkretiny i ikh vliianie na techenie sakharnogo diabeta 2 tipa u patsientov s morbidnym ozhireniem posle bariatricheskikh operatsii. Ozhirenie i metabolizm. 2012; 2: 3–10 (in Russian).]
8. Ершова Е.В., Яшков Ю.И. Состояние углеводного и липидного обмена у пациентов с ожирением и сахарным диабетом 2 типа после билиопанкреатического шунтирования. Ожирение и метаболизм. 2013; 3: 28–36.
[Ershova E.V., Iashkov Iu.I. Sostoianie uglevodnogo i lipidnogo obmena u patsientov s ozhireniem i sakharnym diabetom 2 tipa posle biliopankreaticheskogo shuntirovaniia. Ozhirenie i metabolizm. 2013; 3: 28–36 (in Russian).]
9. Яшков Ю.И., Никольский А.В., Бекузаров Д.К. и др. Cемилетний опыт применения операции билиопанкреатического отведения в модификации Hess–Marceau в лечении морбидного ожирения и сахарного диабета 2 типа. Ожирение и метаболизм. 2012; 2: 43–8.
[Iashkov Iu.I., Nikol'skii A.V., Bekuzarov D.K. et al. Cemiletnii opyt primeneniia operatsii biliopankreaticheskogo otvedeniia v modifikatsii Hess–Marceau v lechenii morbidnogo ozhireniia i sakharnogo diabeta 2 tipa. Ozhirenie i metabolizm. 2012; 2: 43–8 (in Russian).]
10. Buchwald H, Estok R, Fahrbach K et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009; 122: 249–61.
11. Buse J, Caprio S, Cefalu W et al. How do we define cure of diabetes? Diabetes Care 2009; 32: 2133–5.
12. Drucker D. The role of gut hormones in glucose homeostasis. J Clin Invest. 2007; 117: 24–32.
13. Holst J, Vilsboll T, Deacon C. The incretin system and its role in type 2 diabetes mellitus. Mol Cell Endocrinol 2009; 297: 127–36.
14. Mason E. The mechanism of surgical treatment of type 2 diabetes. Obes Surg 2005; 15: 459–61.
15. Nauck M. Unraveling the science of incretin biology. Am J Med. 2009; 122: S3–S10.
16. Rubino F, Gagner M. Potencial of surgery for curing type 2 diabetes mellitus. Ann Surg 2002; 236: 554–9.
17. https://www.idf.org/
18. Patti M, Goldfine A. Hypoglycaemia following gastric bypass surgery: diabetes remission in the extreme? Diabetologia 2010; 53: 2276–9.
19. Rabiee A, Magruder J, Salas-Carrillo R et al. Hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: Unraveling the roles of gut hormonal and pancreatic endocrine dysfunction. J Surg Res 2011; 167: 199–205.
20. Heber D, Greenway F, Kaplan L et al. Endocrine and Nutritional Management of the Post-Bariatric Surgery Patient: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2010; 95 (11): 4823–43.
21. Pories W, Dohm G. Full and Durable Remission of Type 2 Diabetes? Through Surgery? Surg Obes Relat Dis 2009; 5 (2): 285–8.
________________________________________________
1. Bondarenko I.Z., Butrova S.A., Goncharov N.P. et al. Lechenie morbidnogo ozhireniia. Natsional'nye klinicheskie rekomendatsii. Ozhirenie i metabolizm. 2018; 1: 53–70
(in Russian).
2. Fried M, Yumuk V, Oppert J et al. Interdisciplinary European guidelines on metabolic and bariatric surgery. International Federation for the Surgery of Obesity and Metabolic Disorders – European Chapter (IFSO – EC) and European Association for the Study of Obesity (EASO). Obes Surg 2014; 24 (1): 42–55.
3. The Diabetes Surgery Summit Consensus Conference: Recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes. Ann Surg. 2010; 251 (3): 399–405.
4. Iashkov Iu.I., Ershova E.V. "Metabolicheskaia' khirurgiia. Ozhirenie i metabolizm. 2011; 3: 65–8 (in Russian).
5. Flancbaum L. Mechanisms of weight loss after surgery for clinically severe obesity. Obes Surg 1999; 9 (6): 516–23.
6. Buchwald H, Varco R. Metabolic Surgery. New York: Grune & Stratton, 1978.
7. Dedov I.I., Iashkov Iu.I., Ershova E.V. Inkretiny i ikh vliianie na techenie sakharnogo diabeta 2 tipa u patsientov s morbidnym ozhireniem posle bariatricheskikh operatsii. Ozhirenie i metabolizm. 2012; 2: 3–10 (in Russian).
8.Ershova E.V., Iashkov Iu.I. Sostoianie uglevodnogo i lipidnogo obmena u patsientov s ozhireniem i sakharnym diabetom 2 tipa posle biliopankreaticheskogo shuntirovaniia. Ozhirenie i metabolizm. 2013; 3: 28–36 (in Russian).
9. Iashkov Iu.I., Nikol'skii A.V., Bekuzarov D.K. et al. Cemiletnii opyt primeneniia operatsii biliopankreaticheskogo otvedeniia v modifikatsii Hess–Marceau v lechenii morbidnogo ozhireniia i sakharnogo diabeta 2 tipa. Ozhirenie i metabolizm. 2012; 2: 43–8 (in Russian).
10. Buchwald H, Estok R, Fahrbach K et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009; 122: 249–61.
11. Buse J, Caprio S, Cefalu W et al. How do we define cure of diabetes? Diabetes Care 2009; 32: 2133–5.
12. Drucker D. The role of gut hormones in glucose homeostasis. J Clin Invest. 2007; 117: 24–32.
13. Holst J, Vilsboll T, Deacon C. The incretin system and its role in type 2 diabetes mellitus. Mol Cell Endocrinol 2009; 297: 127–36.
14. Mason E. The mechanism of surgical treatment of type 2 diabetes. Obes Surg 2005; 15: 459–61.
15. Nauck M. Unraveling the science of incretin biology. Am J Med. 2009; 122: S3–S10.
16. Rubino F, Gagner M. Potencial of surgery for curing type 2 diabetes mellitus. Ann Surg 2002; 236: 554–9.
17. https://www.idf.org/
18. Patti M, Goldfine A. Hypoglycaemia following gastric bypass surgery: diabetes remission in the extreme? Diabetologia 2010; 53: 2276–9.
19. Rabiee A, Magruder J, Salas-Carrillo R et al. Hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: Unraveling the roles of gut hormonal and pancreatic endocrine dysfunction. J Surg Res 2011; 167: 199–205.
20. Heber D, Greenway F, Kaplan L et al. Endocrine and Nutritional Management of the Post-Bariatric Surgery Patient: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2010; 95 (11): 4823–43.
21. Pories W, Dohm G. Full and Durable Remission of Type 2 Diabetes? Through Surgery? Surg Obes Relat Dis 2009; 5 (2): 285–8.
ФГБУ «Национальный медицинский исследовательский центр эндокринологии» Минздрава России, Москва, Россия
*troshina@inbox.ru
________________________________________________
Endocrinology Research Centre, Moscow, Russia
*troshina@inbox.ru